17 alpha-hydroxylase deficiency (patient information): Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{17 alpha-hydroxylase deficiency (patient information)}} | {{17 alpha-hydroxylase deficiency (patient information)}} | ||
{{CMG}}; {{AE}} {{ | {{CMG}}; {{AE}} {{MJ}} | ||
'''For the WikiDoc page for this topic, click [[ | '''For the WikiDoc page for this topic, click [[17 alpha-hydroxylase deficiency |here]].''' | ||
==Overview== | ==Overview== | ||
Symptoms of | Symptoms of 17 alpha-hydroxylase deficiency include delayed puberty and primary amenorrhea. Mutations in the ''CYP17'' gene cause 17 alpha-hydroxylase deficiency. The most potent risk factor in the development of 17 alpha-hydroxylase deficiency is the presence of [[family history]] of 17 alpha-hydroxylase deficiency. Laboratory findings consistent with the diagnosis of 17 alpha-hydroxylase deficiency include elevated 17α-hydroxyprogesterone, elevated androstenedione, elevated urinary 17-ketosteroids and decreased renin. | ||
==What are the symptoms of | ==What are the symptoms of 17 alpha-hydroxylase deficiency?== | ||
Symptoms of | Symptoms of 17 alpha-hydroxylase deficiency include delayed puberty and primary amenorrhea | ||
==What causes | |||
Mutations in the ''CYP17'' gene cause | ==What causes 17 alpha-hydroxylase deficiency?== | ||
Mutations in the ''CYP17'' gene cause 17 alpha-hydroxylase deficiency. | |||
==Who is at highest risk?== | ==Who is at highest risk?== | ||
The most potent risk factor in the development of | The most potent risk factor in the development of 17 alpha-hydroxylase deficiency is the presence of [[family history]] of this disease. | ||
==Diagnosis== | ==Diagnosis== | ||
Laboratory findings consistent with the diagnosis of | Laboratory findings consistent with the diagnosis of 17 alpha-hydroxylase deficiency include elevated 17α-hydroxyprogesterone, elevated androstenedione, elevated urinary 17-ketosteroids and decreased renin. | ||
==When to seek urgent medical care?== | ==When to seek urgent medical care?== | ||
A person should seek urgent medical care when there are any complications that arise from | A person should seek urgent medical care when there are any complications that arise from 17 alpha-hydroxylase deficiency such as hypertension. | ||
==Treatment options== | ==Treatment options== | ||
The mainstay of therapy for | The mainstay of therapy for 17 alpha-hydroxylase is glucocorticoid therapy. | ||
==Where to find medical care for | ==Where to find medical care for 17 alpha-hydroxylase deficiency?== | ||
[http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+Multiple endocrine neoplasia type 1}}}}&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&sa=N&hl=en&tab=wl Directions to Hospitals Treating | [http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+Multiple endocrine neoplasia type 1}}}}&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&sa=N&hl=en&tab=wl Directions to Hospitals Treating 17 alpha-hydroxylase deficiency] | ||
==Prevention== | ==Prevention== | ||
Prenatal diagnosis of 17 alpha-hydroxylase deficiency is conducted to prevent complication of the disease in future life and treated with prenatal dexamethasone treatment. | Prenatal diagnosis of 17 alpha-hydroxylase deficiency is conducted to prevent complication of the disease in future life and treated with prenatal dexamethasone treatment. | ||
==What to expect (Outlook/Prognosis)?== | ==What to expect (Outlook/Prognosis)?== | ||
The prognosis of | The prognosis of 17 alpha-hydroxylase deficiency is generally good with treatment | ||
==Possible complications== | ==Possible complications== | ||
* Vascular hemorrhage | * Vascular hemorrhage | ||
| Line 33: | Line 35: | ||
==Reference== | ==Reference== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 18:15, 7 August 2017
|
17 alpha-hydroxylase Deficiency |
|
Where to find medical care for 17 alpha-hydroxylase Deficiency? |
|---|
|
17 alpha-hydroxylase Deficiency On the Web |
|
Directions to Hospitals Treating 17 alpha-hydroxylase Deficiency |
|
Risk calculators and risk factors for 17 alpha-hydroxylase Deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
For the WikiDoc page for this topic, click here.
Overview
Symptoms of 17 alpha-hydroxylase deficiency include delayed puberty and primary amenorrhea. Mutations in the CYP17 gene cause 17 alpha-hydroxylase deficiency. The most potent risk factor in the development of 17 alpha-hydroxylase deficiency is the presence of family history of 17 alpha-hydroxylase deficiency. Laboratory findings consistent with the diagnosis of 17 alpha-hydroxylase deficiency include elevated 17α-hydroxyprogesterone, elevated androstenedione, elevated urinary 17-ketosteroids and decreased renin.
What are the symptoms of 17 alpha-hydroxylase deficiency?
Symptoms of 17 alpha-hydroxylase deficiency include delayed puberty and primary amenorrhea
What causes 17 alpha-hydroxylase deficiency?
Mutations in the CYP17 gene cause 17 alpha-hydroxylase deficiency.
Who is at highest risk?
The most potent risk factor in the development of 17 alpha-hydroxylase deficiency is the presence of family history of this disease.
Diagnosis
Laboratory findings consistent with the diagnosis of 17 alpha-hydroxylase deficiency include elevated 17α-hydroxyprogesterone, elevated androstenedione, elevated urinary 17-ketosteroids and decreased renin.
When to seek urgent medical care?
A person should seek urgent medical care when there are any complications that arise from 17 alpha-hydroxylase deficiency such as hypertension.
Treatment options
The mainstay of therapy for 17 alpha-hydroxylase is glucocorticoid therapy.
Where to find medical care for 17 alpha-hydroxylase deficiency?
Directions to Hospitals Treating 17 alpha-hydroxylase deficiency
Prevention
Prenatal diagnosis of 17 alpha-hydroxylase deficiency is conducted to prevent complication of the disease in future life and treated with prenatal dexamethasone treatment.
What to expect (Outlook/Prognosis)?
The prognosis of 17 alpha-hydroxylase deficiency is generally good with treatment
Possible complications
- Vascular hemorrhage
- Renal insufficiency
- Left ventricular hypertrophy
- Hypertensive retinopathy
- Stroke